Fuzheng Jiedu granules against disease progression among high-risk adults with non-severe COVID-19: a multicenter retrospective cohort study

Fuzheng Jiedu granules against disease progression among high-risk adults with non-severe COVID-19: a multicenter retrospective cohort study

BackgroundFuzheng Jiedu (FZJD) granules are widely used to treat coronavirus disease (COVID-19) since their market approval, but their clinical effectiveness remains uncertain. In this study, we aimed to evaluate the effectiveness of FZJD in reducing disease progression in high-risk adults with COVI...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiaoli Hua, Danwen Zheng, Jingwei Shui, Tong Zhang, Shengle Qin, Hanhong Zhang, Bo Yu, Longde Wang, Hailang He, Xinghua Tan, Qiumin Chen, Yang Yang, Weng Heng, Yihang Cai, Xiaohua Xu, Qing Liu, Yuntao Liu, Rongyuan Yang, Zhongde Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Pharmacology
Subjects:
COVID-19
Fuzheng Jiedu granules
traditional Chinese medicine
high-risk patients
disease progression
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1523004/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2025.1523004/full

Similar Items